Xiangya Hospital Of Central South University
Clinical trials sponsored by Xiangya Hospital Of Central South University, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- AI reads scans to spot prostate cancer, spare unnecessary biopsies Results expected Sep 2026 (estimated)
- New pain drug aims to get your gut moving again after surgery Results expected Dec 2026 (estimated)
- Blood test could slash unnecessary antibiotics in pancreatitis patients Results expected Dec 2026 (estimated)
- Can brain waves predict thinking problems after sepsis? Results expected Dec 2026 (estimated)
- Could a magnetic helmet help kids with delayed speech? Results expected Dec 2026 (estimated)
-
Second chance: new combo aims to clear hepatitis c after relapse
Disease control OngoingThis study tests a 12-week course of three antiviral drugs (sofosbuvir, velpatasvir, and voxilaprevir) in 200 adults with chronic hepatitis C whose virus returned after previous treatment. The main goal is to see if the virus becomes undetectable 12 weeks after therapy ends. Rese…
Sponsor: Xiangya Hospital of Central South University • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
New triple therapy takes on untreatable liver cancer
Disease control By invitation onlyThis early-phase trial is testing a combination of an experimental drug (JS014), an immunotherapy (toripalimab), and a targeted chemotherapy procedure (TACE) in 20 people with advanced liver cancer that cannot be surgically removed. The main goal is to check safety, but researche…
Phase 1 • Sponsor: Xiangya Hospital of Central South University • Aim: Disease control
Last updated Jun 26, 2026 19:07 UTC
-
AI reads scans to spot prostate cancer, spare unnecessary biopsies
Diagnosis By invitation onlyThis study aims to develop an artificial intelligence (AI) model that combines two advanced imaging techniques—multiparametric MRI and PSMA PET/CT—to more accurately diagnose prostate cancer. By analyzing data from up to 1,500 patients, the AI model is designed to identify clinic…
Sponsor: Xiangya Hospital of Central South University • Aim: Diagnosis
Last updated Jul 10, 2026 00:00 UTC
-
Can sound waves clear up skin? new trial tests ultrasound for pigment and rosacea
Symptom relief OngoingThis study tests whether microfocused ultrasound can safely improve facial pigmentary diseases (like melasma) and rosacea. Two hundred adults will be randomly assigned to receive either real ultrasound or a sham (fake) treatment once a month for six months. Researchers will track…
Sponsor: Xiangya Hospital of Central South University • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
AI reads biopsies to predict cancer spread
Knowledge-focused By invitation onlyThis study is testing whether artificial intelligence can predict if prostate cancer has spread to lymph nodes or other parts of the body by analyzing biopsy tissue images. Researchers will use samples from 3,000 men to develop and validate the AI model. The goal is to help docto…
Sponsor: Xiangya Hospital of Central South University • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC